Skip to main content
Log in

Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity

  • Article
  • Published:

From Nature Genetics

View current issue Submit your manuscript

Abstract

Huntington disease (HD) is caused by expansion of a glutamine repeat in the amino-terminal region of huntingtin. Despite its widespread expression, mutant huntingtin induces selective neuronal loss in striatal neurons. Here we report that, in mutant mice expressing HD repeats, the production and aggregation of N-terminal huntingtin fragments preferentially occur in HD-affected neurons and their processes and axonal terminals. N-terminal fragments of mutant huntingtin form aggregates and induce neuritic degeneration in cultured striatal neurons. N-terminal mutant huntingtin also binds to synaptic vesicles and inhibits their glutamate uptake in vitro. The specific processing and accumulation of toxic fragments of N-terminal huntingtin in HD-affected striatal neurons, especially in their neuronal processes and axonal terminals, may contribute to the selective neuropathology of HD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1: Specific localization of huntingtin aggregates in HD-repeat mutant mouse brain.
Figure 2: Age-dependence of intranuclear and neuropil aggregates in HD-repeat mutant mice.
Figure 3: Huntingtin aggregates associated with N-terminal huntingtin fragments.
Figure 4: Comparison of huntingtin aggregates in R6/2 mice and HD-repeat mutant mice.
Figure 5: Effect of N-terminal huntingtin fragments on cultured striatal neurons.
Figure 6: Effect of N-terminal huntingtin fragments on synaptic vesicles and their glutamate uptake in vitro.

Similar content being viewed by others

References

  1. HD Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971– 983 (1993).

  2. Vonsattel, J.P. et al. Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol. 44, 559– 577 (1985).

    Article  CAS  Google Scholar 

  3. Davies, S.W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537–548 ( 1997).

    Article  CAS  Google Scholar 

  4. Schilling, G. et al. Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin. Hum. Mol. Genet. 8, 397–407 ( 1999).

    Article  CAS  Google Scholar 

  5. Hodgson, J.G. et al. A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration . Neuron 23, 181–192 (1999).

    Article  CAS  Google Scholar 

  6. DiFiglia, M. et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990–1993 (1997).

    Article  CAS  Google Scholar 

  7. Becher, M.W. et al. Intranuclear neuronal inclusions in Huntington's disease and dentatorubral and pallidoluysian atrophy: correlation between the density of inclusions and IT15 CAG triplet repeat length. Neurobiol. Dis. 4, 387–397 ( 1998).

    Article  CAS  Google Scholar 

  8. Gutekunst, C.A. et al. Nuclear and neuropil aggregates in Huntington's disease: relationship to neuropathology. J. Neurosci. 19, 2522 –2534 (1999).

    Article  CAS  Google Scholar 

  9. Saudou, F., Finkbeiner, S., Devys, D. & Greenberg, M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55–66 (1998).

    Article  CAS  Google Scholar 

  10. Li, H. et al. Ultrastructural localization and progressive formation of neuropil aggregates in Huntington's disease transgenic mice. Hum. Mol. Genet. 8, 1227–1236 ( 1999).

    Article  CAS  Google Scholar 

  11. Shelbourne, P.F. et al. A Huntington's disease CAG expansion at the murine Hdh locus is unstable and associated with behavioural abnormalities in mice . Hum. Mol. Genet. 8, 763– 774 (1999).

    Article  CAS  Google Scholar 

  12. Ferrante, R.J., Kowall, N.W., Cipolloni, P.B., Storey, E. & Beal, M.F. Excitotoxin lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization . Exp. Neurol. 119, 46– 71 (1993).

    Article  CAS  Google Scholar 

  13. Hackam, A.S. et al. The influence of huntingtin protein size on nuclear localization and cellular toxicity. J. Cell Biol. 141, 1097–1105 (1998).

    Article  CAS  Google Scholar 

  14. Wheeler, V.C. et al. Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh(Q92) and Hdh(Q111) knock-in mice. Hum. Mol. Genet. 9, 503– 513 (2000).

    Article  CAS  Google Scholar 

  15. Albin, R.L. & Greenamyre, J.T. Alternative excitotoxic hypotheses . Neurology 42, 733–738 (1992).

    Article  CAS  Google Scholar 

  16. Beal, M.F. Huntington's disease, energy, and excitotoxicity. Neurobiol. Aging 15, 275–276 ( 1994).

    Article  CAS  Google Scholar 

  17. Usdin, M.T., Shelbourne, P.F., Myers, R.M. & Madison, D.V. Impaired synaptic plasticity in mice carrying the Huntington's disease mutation . Hum. Mol. Genet. 8, 839– 846 (1999).

    Article  CAS  Google Scholar 

  18. Reiner, A. et al. Differential loss of striatal projection neurons in Huntington disease. Proc. Natl Acad. Sci. USA 85, 5733 –5737 (1988).

    Article  CAS  Google Scholar 

  19. Albin, R.L. et al. Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann. Neurol. 31, 425–430 (1992).

    Article  CAS  Google Scholar 

  20. Ellerby, L.M. et al. Kennedy's disease: caspase cleavage of the androgen receptor is a crucial event in cytotoxicity. J. Neurochem. 72 , 185–195 (1999).

    Article  CAS  Google Scholar 

  21. Igarashi, S. et al. Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet. 18, 111– 117 (1998).

    Article  CAS  Google Scholar 

  22. Li, S.H., Gutekunst, C.A., Hersch, S.M. & Li, X.J. Interaction of huntingtin-associated protein with dynactin P150Glued. J. Neurosci. 18, 1261–1269 (1998).

    Article  CAS  Google Scholar 

  23. Ivkovic, S. & Ehrlich, M.E. Expression of the striatal DARPP-32/ARPP-21 phenotype in GABAergic neurons requires neurotrophins in vivo and in vitro . J. Neurosci. 19, 5409– 5419 (1999).

    Article  CAS  Google Scholar 

  24. Xia, Z., Dudek, H., Miranti, C.K. & Greenberg, M.E. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 16, 5425–5436 (1996).

    Article  CAS  Google Scholar 

  25. Kish, P.E. & Ueda, T. Glutamate accumulation into synaptic vesicles. Methods Enzymol. 174, 9– 25 (1989).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank N. Ciliax for assistance in culturing striatal neurons; P. Thumfort for the GST–67Q DNA construct; C.A. Gutekunst and S. Hersch for antibody mHD549; and D. Danner for comments. This work was supported by grants from the NIH, Hereditary Disease Foundation, Huntington's Disease Society of America, and The Cunningham Trust (to P.F.S.).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xiao-Jiang Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, H., Li, SH., Johnston, H. et al. Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nat Genet 25, 385–389 (2000). https://doi.org/10.1038/78054

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/78054

  • Springer Nature America, Inc.

This article is cited by

Navigation